2003 Warkany Lecture: Autism as a Birth Defect

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 1, 2004, Pages 1-6

  Rodier, Patricia M ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Autism; Autism spectrum disorders; Birth defect; Developmental disorder

Indexed keywords

THALIDOMIDE;

ALLELE; AUTISM; BIRTH DEFECT; COMORBIDITY; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; DIAGNOSTIC VALUE; DNA POLYMORPHISM; EMBRYOLOGY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC DISORDER; HUMAN; MEDICAL RESEARCH; MOEBIUS SYNDROME; NONHUMAN; PRIORITY JOURNAL; SYMPTOMATOLOGY; TERATOGENESIS;

ANIMALS; AUTISTIC DISORDER; COMORBIDITY; DISEASE MODELS, ANIMAL; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS;

EID: 1042301324     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10152     Document Type: Conference Paper

References (54)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders - DSMIV. Washington, DC: APA, pp. 66-67.
2. Appukuttan B, Gillanders E, Juo S, et al. 1999. Localization of a gene for Duane retraction syndrome to chromosome 2q31. Am J Hum Genet 65:1639-1649.
3. Arndt TL, Tisdale B, Stodgell CJ, et al. 2003. Stereological study of the deep cerebellar nuclei in rats exposed to valproic acid in utero. Poster presented at the annual meeting of the Teratology Society, Philadelphia PA. June.
4. Bailey A, Le Couteur A, Gottesman I, et al. 1995. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25:63-78.
5. Bailey A, Luthert P, Dean A, et al. 1998. A clinicopathological study of autism. Brain 121:889-905.
6. Bandim JM, Ventura LO, Miller MT, et al. 2003 Autism and Moebius sequence, an exploratory study of children in northeastern Brazil. Arq Neuropsiquiatr 61:181-185.
7. Bauman ML, Kemper TL. 1994. Neuroanatomic observations in autism. In: Bauman ML, Kemper TL, editors. The neurobiology of autism. Baltimore: Johns Hopkins University Press. pp. 119-145.
8. Buxbaum JD, Silverman JM, Smith CJ, et al. 2001. Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet 68:1514-1520.
9. Bayer SA, Altman J, Russo RJ, Zhang X. 1993. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14:83-144.
10. Carpenter EM, Goddard JM, Chisaka O, Manley NR. 1993. Loss of Hox-A1 (Hox-1.6) function results in the reorganization of the murine hind-brain. Development 118:1063-1075.
11. Chakrabarti S, Fombonne E. 2001. Pervasive developmental disorders in preschool children. JAMA. 285:3093-3099.
12. Chess S. 1977. Follow-up reporton autism in congenital rubella. J Aut Child Schiz 7:69-81.
13. Christianson AL, Chesler N, Kromberg JGR. 1994. Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs. Dev Med Child Neurol 36:357-369.
14. Czapinski P, Bryson SE. 2003. Reduced facial muscle movements in autism: evidence for dysfunction in the neuromuscular pathway. Brain Cogn 51:177-179.
15. Gillberg C, Steffenberg S. 1989. Autistic behavior in Moebius syndrome. Acta Paediatr Scand 78:314-316.
16. Gonzalez CH, Marques-Dias MJ, Kim CA, et al. 1998. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 351:1624-1627.
17. Gonzalez CH, Vargas FR, Perez ABA, et al. 1993. Limb deficiency with or without Möbius sequence in seven Brizilian chidren associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet 47:59-64.
18. Ingram JL, Peckham SM, Tisdale B, Rodier PM. 2000a. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 22:319-324.
19. Ingram JL, Stodgell CJ, Hyman SL, et al. 2000b. Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology 63:393-405.
20. Johansson M, Wentz E, Fernell E, et al. 2001. Autistic spectrum disorder in Mobius sequence: a comprehensive study of 25 individuals. Dev Med Child Neurol 43:338-345.
21. Lord C, Rutter M, Goode S, et al. 1989. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 19:185-212.
22. Lord C, Rutter M, Le Couteur A. 1994. Autism Diagnostic Interview - Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659-685.
23. Mark M, Lufkin T, Vonesch J-L, Ruberte E, Olivo J-L, Dolle P, Gorry P, et al. 1993. Two rhombomeres are altered in Hoxa-1 mutant mice. Development 119:319-338.
24. Martinez S. 2001. The isthmic organizer and brain regionalization. Int J Dev Biol 45:367-371.
25. McConnell B, Drmic I, Roberts W, Bryson SE. 2002. The co-occurrence of autistic spectrum disorders and Moebius syndrome: data from the ADI-R and ADOS-G. Presented at the International Meeting for Autism Research, Orlando, FL. November.
26. Miller MT. 1991. Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus [Review]. Trans Am Ophthalmol Soc 89:623-674.
27. Miller MT, Strömland K. 1999. Teratogen update: thalidomide: a review with a focus on ocular finds and new potential uses. Teratology 60:306-321.
28. Miller MT, Ventura L. 2001. Moebius syndrome/sequence: a summary of a Brazil study. Teratology 63:260.
29. Moore SJ, Turnpenny P, Quinn A, et al. 2000. A clinical study of 57 children with fetal anticonvulsant syndrome. J Med Genet 37:489-497.
30. Murphy P, Hill RE. 1991. Expression of the mouse labial-like homeobox-containing genes, Hox 2,9 and Hox 1.6, during segmentation of the hindbrain. Development 111:61-74.
31. Nanson JL. 1992. Autism in fetal alcohol syndrome: a report of six cases. Alcohol Clin Exp Res 16:558-565.
32. Nowack E. 1965. Die sensible Phase bei der thalidomide-embryopathie. Humangenetik 1:516-536. [Ger]
33. Persico AM, D'Agruma L, Maiorano N, et al. 2001. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 6:150-159.
34. Persico AM, Stodgell C, D'Agruma L, et al. 2002. The HOXA1 G allele may be associated with dysmorphism in autism. Am J Hum Genet 71(Suppl):478.
35. Risch N, Spiker D, Lotspeich L, et al. 1999. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 65:493-507.
36. Rodier PM, Ingram JL, Tisdale B, et al. 1996. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 370:247-261.
37. Rodier PM, LaPoint S. 2001. Stereology of the inferior olive in valproate-exposed rats. Presented at the International Meeting for Autism Research, San Diego, CA. November.
38. Rosenhall U, Johansson E, Gillberg C. 1988. Oculomotor findings in autistic children. J Laryngol Otol 102:435-439.
39. Scharré JE, Creedon MP. 1992. Assessment of visual function in autistic children. Optom Vis Sci 69:433-439.
40. Schumacher HJ, Terapane J, Jordan RL, Wilson JG. 1968. The teratogenic activity of a thalidomide analogue, EM12, in rabbits, rats, and monkeys. Teratology 5:233-240.
41. Sears LL, Finn PR, Steinmetz J. 1994. Abnormal classical eye-blink conditioning in autism. J Autism Dev Disord 24:737-751.
42. Smith M, Escamilla JR, Filipek P, et al. 2001. Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR. Cytogenet Cell Genet 94:15-22.
43. Stanton ME, Erwin RJ, Rush AN, et al. 2001. Eyeblink conditioning in autism and a developmental rodent model. Neurotoxicol Teratol 23:297.
44. Stanton ME, Peloso ED, Brown KL, Pagani JH. 2003. Discriminative eye-blink conditioning and reversal in a rodent model of autism. Neurotoxicol Teratol (in press).
45. Steg JP, Rapoport JL. 1975. Minor physical anomalies in normal, neurotic, learning disabled, and severely disturbed children. J Autism Child Schizophr 5:299-307.
46. Stodgell CJ, Ingram JL, Gnall S, Rodier PM. 2001. In utero valproic acid alters Hoxa1 expression in the rat embryo: mechanism of teratogenicity and relationship to autism. Teratology 63:247.
47. Stodgell CJ, Wanek N, O'Bara M, et al. 2003. Association of HOXD1 and GBX2 allelic variants with autism spectrum disorders. Am J Hum Genet 73(Suppl 1):470.
48. Strömland K, Nordin V, Miller M, et al. 1994. Autism in thalidomide embryopathy: a populafion study. Dev Med Child Neurol 36:351-356.
49. Strömland K, Miller MT, Ekman-Joelsson B-M, et al. 2003. Malformations in CHARGE association arise during a limited time period of early pregnancy [Abstract]. Birth Defects Res Part A Clin Mol Teratol 67:316.
50. Walker HA. 1977. Incidence of minor physical anomaly in autism. J Autism Child Schizophr 7:165-176.
51. Wanek N, O'Bara M, Stodgell CJ, Rodier PM. 2002. Transmission disequilibrium of a variant allele of HOXD1 in autism spectrum disorders. Teratology 65:304.
52. Wassink TH, Piven J, Vieland VJ, Huang J, et al. 2001. Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet. 105:406-413.
53. Williams PG, Hersh JH. 1997. A male with fetal valproate syndrome and autism. Dev Med Child Neurol 39:632-634.
54. Williams PG, King J, Cunningham M, et al. 2001. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 43:202-206.